semaglutide hypoglycemia risk Indications for oral Cardiovascular Outcomes, Safety, and Tolerability

If you have liver disease, pancreatitis history, alcohol use disorder, or other complex medical conditions, specialized guidance is essential.

Evidence suggests that losing bone mass during a weight loss journey may increase the risk of certain chronic conditions

Employers looking to add GLP-1 drug coverage specifically for weight loss to their health plans will be best-served by working in conjunction with clinical data experts who can help assess benefit design, address potential increases in drug spending, and incorporate healthcare benefits with effective behavioral modification and support programs

Moreover, small reductions in body weight alone can have beneficial effects on blood pressure as well as glucose and cholesterol metabolism (Klein et al., 2004

For example, patients with a history of unsuccessful dieting or those facing serious health risks due to excess weight may find semaglutide therapy to be an appropriate option